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Background: Inflammatory bowel disease (IBD) is a chronic inflammation of the intestinal epithelium that is driven
by the intestinal immune system, oxidative stress and the loss of tolerance to the luminal microbiota. The use of
dietary products containing ingredients such as fibres and carbohydrates and/or antioxidant compounds have been
used as a therapeutic strategy for intestinal diseases because these products are considered effective in the
modulation of the immune system and colonic microbiota. We investigated the beneficial effects of cattail rhizome
flour (Typha angustifolia L.) in the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. In addition, we
investigated the effects of cattail rhizome flour on the intestinal anti-inflammatory activity of prednisolone, which is
a reference drug that is used for treatment of human IBD.
Methods: The present study included the preparation of flour from rhizomes of cattail (Typha angustifolia L.); an
evaluation of the qualitative phytochemical profile of cattail rhizomes; an evaluation of the efficacy of cattail
rhizome flour in TNBS-induced rat colitis; an evaluation of the synergistic effects of cattail rhizome flour on the
intestinal anti-inflammatory activity of prednisolone; and macroscopic, clinical, biochemical, histopathological and
microbiological studies to assess the healing effects of cattail rhizome flour and its synergistic effects in
TNBS-induced rat colitis. The data were analysed by ANOVA, Kruskal-Wallis and χ2 tests.
Results: We tested several concentrations of cattail rhizome flour and found that dietary supplementation with 10%
cattail rhizome flour showed the best effects at reducing the extension of the lesion, the colon weight ratio,
adherences to adjacent organs and diarrhoea. These effects were related to inhibition of myeloperoxidase (MPO)
and alkaline phosphatase (AP) activities and an attenuation of glutathione (GSH) depletion. The 10% cattail rhizome
flour was as effective as prednisolone, and no synergistic effects were observed. Saponins, flavonoids and coumarins
were detected in the rhizome flour. No changes were observed in the total number of lactic bacteria after dietary
supplementation with cattail rhizome flour.
Conclusions: Dietary supplementation with 10% cattail rhizome flour and its combination with prednisolone prevent
TNBS-induced colonic damage in rats, but no synergistic effects were observed. The prevention of
TNBS-induced colon damage was associated with an improvement in intestinal oxidative stress, which likely resulted
from the antioxidant properties of the active compounds detected in the cattail rhizome. This protective effect was
not related to an improvement in lactic bacteria counts.* Correspondence: ldistasi@ibb.unesp.br
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Inflammatory Bowel Disease (IBD) is a collective term
for a group of chronic intestinal inflammation states of
the small and/or large intestines that encompasses
ulcerative colitis (UC), a chronic mucosal and sub-mucosal
inflammation of the large intestine and rectum, and
Crohn’s disease (CD), a chronic transmural inflammation
of all/any part of the gastro-intestinal tract [1]. Although
much progress has been made in understanding the
pathogenesis of human IBD, its aetiology has not been
defined [2]; however, development of tissue injury is
attributed to immune system alterations, reactive oxygen
species and the loss of normal tolerance to the host [3-5].
Interestingly, there is increasing experimental evidence
to support a role for luminal bacteria in the initiation
and development of the intestinal inflammatory process,
and this is probably related to an imbalance in the intes-
tinal microflora (i.e., a relative predominance of aggres-
sive bacteria and an insufficient amount of protective
species) [1,5,6].
Dietary components, primarily dietary fibre, have proven
to be beneficial in maintaining remission in human and
experimental ulcerative colitis, and the protective effect of
fibre is related to an increase in the luminal production of
short-chain fatty acids (SCFAs), including acetate, propi-
onate and butyrate [7]. Butyrate has been reported to be
an important factor in the maintenance of healthy function
in colorectal mucosa and the major fuel source for colono-
cytes [8]. Several studies have suggested that some food
products, including dietary fibre, germinated barley food-
stuff, inulin, lactulose and polydextrose, exert beneficial
effects in experimental and human intestinal inflammatory
processes [7-13].
Typha angustifolia L. is a perennial aquatic macrophyta
from the Typhaceae family that grows over broad climate
and habitat ranges. This plant is named as taboa (Brazil),
Lesser Bulrush (Britain) and narrow-leaved cattail or cat-
tail (North America and other countries). T. angustifolia is
characterised by its fast growth and high biomass [14].
Interestingly, several parts of the plant are edible, includ-
ing dormant sprouts on the roots and bases of the leaves,
ripe pollen, the stem and the starchy roots [15,16]. T.
angustifolia and other species of the genus Typha are
widely used as medicinal plants. In Brazil, Latin America
and North America, the leaves are used as a diuretic, an
astringent, a desiccant, a haemostatic agent and a vulner-
ary. In addition, the rhizomes are used as a diuretic, an
astringent and an antimycobacterial. Moreover, the
pollen is used in the treatment of scrofula, abscesses and
abdominal pain, and the powder of the fuzz and rhizomes
are used to prevent chafing, sores, inflammation, kid-
ney stones and diarrhoea [17-20]. The rhizomes of T.
angustifolia pods are also characterised by high fibre
(17.20 g/100 g of flour) and carbohydrate (67.29 g/100 g flour) contents, and they are known to be rich in
starch granules [16,21,22], which can be used by colonic
microbiota as substrates for anaerobic fermentation and
the production of SCFAs.
The current pharmacological treatments that are avail-
able for IBD include corticosteroids, aminosalicylates,
immunosupressants and anti-TNF-α antibodies, but
these pharmacological therapies are associated with ser-
ious side effects, particularly after long-term use. Gluco-
corticoids are widely used in the treatment of IBD in UC
and CD patients, but glucocorticoids are not a long-term
solution for anyone with IBD because they result in
numerous unwanted side effects and can damage organ
function years after ingestion, particularly if a high dose
was administered for longer than 6 months [23]. Dissat-
isfaction with current conventional therapies has resulted
in an increased use of complementary and alternative
medicinal approaches, including dietary components
with biological activity, such as fibre and other prebiotics
and probiotics, which are currently estimated to be used
in 49.5% of cases [24,25].
Given that cattail rhizome flour (T. angustifolia L.) is a
medicinal plant used to treat inflammation and related
disease and is an important source of dietary fibre and
carbohydrates, the aim of the present study was to evalu-
ate if dietary supplementation with cattail rhizome flour
could act as a prebiotic and produce protective effects
on the intestinal inflammatory process. In addition, we
also investigated whether the combination of dietary
supplementation with prednisolone, which causes serious
side effects after long-term use, has synergistic effects.
Methods
Chemicals
All chemicals were obtained from Sigma (St. Louis, MO,
USA).
Plant material and diet preparation
The rhizomes of cattail (T. angustifolia L.) were collected
in Botucatu city, São Paulo, Brazil, in September 2009.
The plant material was authenticated by taxonomists
from Irina Delanova Gemtchujnicov Herbarium (Insti-
tute of Biosciences, São Paulo State University, UNESP),
where a voucher was deposited under numbers Botu
2767, Botu 2768, and Botu 2769.
After collection, the fresh cattail rhizomes were
washed, chopped and dried at 50°C for 72 hr in a hot-
house with forced air circulation and renewal. After dry-
ing, the rhizomes were powdered to produce flour. The
final yield of cattail rhizome flour was 11% relative to
the fresh weight. The flour was added at a ratio of 5%, 10%
or 20% in previously sprayed animal feed (Labina-Purine).
After homogenisation and pelletisation, the diet con-
taining 5%, 10% and 20% of the cattail rhizome flour
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composition of the diets is shown in Table 1.
Phytochemical analysis of cattail rhizome flour
The phytochemical profile of the cattail rhizome flour
was determined according to previously described meth-
ods [26]. Briefly, a 70% methanol/water extract from cat-
tail rhizome flour (300 g) was prepared by percolation. A
portion of this extract (150.0 mL) was hydrolysed to pro-
duce a hydrolysed extract. In addition, an ether extract
(300 g cattail rhizome flour) was prepared in a Soxhlet
apparatus. The three extracts were submitted to phyto-
chemical reactions for detection of the fixed acids, alka-
loids, anthocyanins, anthocyanidins, aurones, antranols,
quartenary bases, catechins, chalcones, cyanogenic het-
erosides, coumarins, flavones, flavonols, flavanones, fla-
vononols, phenols, quinones, resins, saponins, steroids,
triterpenoids and xanthones.
Animals
Male Wistar rats (weighing 200–220 g) from the Central
Animal House, São Paulo State University, UNESP, Botu-
catu city, SP, Brazil, were housed in standard environmen-
tal conditions (21°C, 60-70% humidity) under a 12-hour
light/dark cycle and air filtration. The rats had free access
to water and food (Labina-Purine, Brazil). The experimen-
tal protocol met the Guidelines of Animal Experimenta-
tion and was approved by the Commission of Ethics in
Animal Experimentation (protocol number 042/04-CEAE),Table 1 Ingredient composition of the diets fed to rats
(g/100 g)






Protein mix 23.0 21.85 20.7 18.5
Mineral mix1 12.0 11.40 10.8 9.7
Fiber 5.0 4.75 4.5 3.6
Vitamin mix2 1.0 0.95 0.9 0.8
Fat 10.0 9.5 9.0 8.0
Fatty acids 5.5 5.22 4.95 4.4
Corn starch 32.0 30.40 28.8 25.7
Sugar mix 6.0 5.7 5.4 4.9
Soybean meal 2.5 2.38 2.25 2.0
Wheat bran 3.0 2.85 2.7 2.4
Cattail flour3 - 5.0 10.0 20.0
1 Mineral mixture provided the following amounts (mg/Kg): Mg, 1.7; Mn, 110.0;
I, 1.0; Co, 2.0; Fe, 180.0; Zn, 110.0; Cu, 30.0, Se, 0.2, Na, 2.8, P, 8.5; Ca, 13.0.
2Vitamin mixture provided the following amounts (mg/Kg/diet): vitamin A
(25600 UI); vitamin D3 (4000 UI); vitamin E (82 mg); vitamin K (6.4 mg), vitamin
B12 (40 μg); vitamin B6 (11 mg), folic acid (13 mg); choline (2800 mg), biotin
(0.16 mg), niacin (220 mg), thiamine (11 mg). pantothenic acid (90 mg)
3Rhizomes of cattail (Typha angustifolia L.) containing total fiber (17.25),
protein (5.81%), lipids (0.90%), ash (8.80%) and non-nitrogenated coumpounds
(67.29%) [15].Institute of Biosciences, São Paulo State University–
UNESP.
Experimental design and induction of experimental colitis
The rats were randomly assigned into ten groups with
eight animals in each. Two noncolitic groups were used:
the first received normal diet and the second received an
enriched diet that consisted of 20% of cattail rhizome
flour for 21 days. The colitic rats were divided into eight
groups. A TNBS control group received normal diet for
14 days prior to the induction of colitis and 7 days there-
after. Three colitic groups received an enriched diet with
5%, 10% or 20% of cattail rhizome flour in the same con-
ditions as the TNBS control group. Three additional
colitic groups received an enriched diet with 5%, 10% or
20% of cattail rhizome flour plus prednisolone orally
administered at a dose of 2 mg/kg for 3 days prior to the
induction of colitis and 7 days thereafter. To assess the
effects of prednisolone alone, the remaining group
received only prednisolone (2 mg/kg) for 3 days prior to
the induction of colitis and 7 days thereafter. Prednisol-
one was administered by means of an oesophageal cath-
eter (5 ml/kg). Rats from the noncolitic and the
nontreated colitic groups were orally administered water.
Colitis was induced using a previously described method
[27]. After an overnight fast, the rats were anaesthetised
with halothane and given 10 mg of TNBS dissolved in
0.25 ml of 50% (vol/vol) ethanol using a Teflon cannula
(Dupont, Wilmington, DE, USA) inserted 6–8 cm into
the anus. During and after TNBS administration, the rats
were kept in a head-down position until they recovered
from the anaesthesia. The rats in the noncolitic group
received 0.25 ml of saline. The rats in all the groups were
euthanised 7 days after the induction of colitis by an
overdose of halothane.
Assessment of colonic damage
Animal body weights, the occurrence of diarrhoea (as
detected by perianal fur soiling), and total food intake
for each group were recorded daily. Once the rats were
killed, the colon was removed aseptically, placed on an
ice-cold plate, longitudinally opened, and the luminal
contents were collected for the microbiological studies
(see below). After the tissue collection, the colonic seg-
ment was cleaned of fat and mesentery and blotted on
filter paper. Each specimen was weighed, and its length
was measured under a constant load (2 g). Using previ-
ously described criteria [28], the colon was scored for
macroscopically visible damage on a 0–10 scale by two
observers who were unaware of the treatment (no dam-
age: 0; no ulcer, hyperaemia: 1; linear ulcer with no sig-
nificant inflammation: 2; linear ulcer with inflammation
at one site: 3; ≥ 2 sites of ulceration/inflammation: 4; ≥ 2
major sites of ulceration and inflammation or one site of
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of the colon: 5; if damage covers 2 cm along the length
of the colon, the score is increased by 1 for each add-
itional centimetre of involvement: 6 to 10). The colon
was divided into different longitudinal pieces to be used
for the following biochemical determinations: myeloper-
oxidase (MPO) activity, alkaline phosphatase (AP) activ-
ity and total glutathione (GSH) content.
Microscopic assessment of colitis
Prior to the collection of longitudinal pieces for
biochemical analysis, representative transversal whole-
gut specimens were taken from a region of the inflamed
colon that corresponded to the segment adjacent to the
gross macroscopic damage, and the specimens were fixed
in 4% buffered formaldehyde. Cross-sections were
selected and embedded in paraffin. Equivalent colonic
segments were also obtained from the noncolitic group.
Full thickness sections of 5 mm were obtained at differ-
ent levels and were stained with haematoxylin and eosin.
The histological damage was evaluated by one observer
who was blinded to the experimental groups as previ-
ously described [29].
Biochemical evaluation
MPO activity was determined according to the technique
described by Krawisz et al. [30]. The results are
expressed as MPO units/g of tissue. One unit of MPO
activity was defined as the amount required to degrade
1 mmol of hydrogen peroxide/min at 25°C.
AP activity was determined spectrophotometrically
using disodium nitrophenylphosphate (5.5 mM) as the
substrate in 50 mM glycine buffer with 0.5 mM MgCl2
at pH 10.5 [31]. The enzymatic activity is expressed as
mU/mg of protein [32].
GSH content was quantified with the recycling assay
as described by Anderson et al. [33], and the results are
expressed as nmol/g of wet tissue.
Antioxidant activity
Additional in vitro experiments were performed to test
the antioxidant activity of different concentrations of cat-
tail rhizome flour (2.5–1400 μg/ml). The antioxidant
activity was evaluated by inhibition of induced lipid
peroxidation in rat brain membrane as previously
described [34]. The flavonoid quercetin was used as a
reference and tested in the same assay system.
Microbiological studies
Luminal content samples were weighed, homogenised,
and serially diluted in sterile 0.85% saline. Serial 10-fold
dilutions of homogenates were plated on Man Rogosa
and Sharp Agar (MRS), a specific medium for lactic acid
bacteria, and incubated under microaerobic conditions(5% CO2) at 35°C for 120 hr. After the incubation, the
final count of colonies was reported as log10 colony-
forming units per gram of faecal material.
Statistical analysis
All results are expressed as mean ± SEM, and differences
between the means were tested for statistical significance
using one-way analysis of variance and post hoc least
significance tests. Nonparametric data (scores) are
expressed as the median (range) and were analysed with
a Kruskal-Wallis test. Differences between proportions
were analysed with a χ2 test. Statistical significance was
set at p< 0.05.
Results
Macroscopic, biochemical and histological evaluation
TNBS instillation resulted in colonic inflammation,
which was evident after 7 days by severe necrosis of the
mucosa (typically extending 2.71–3.37 cm along the
colon), bowel wall thickening, and hyperaemia (Table 2).
TNBS-induced colon inflammation was associated with
a significant increase in the colonic weight/length ratio,
the incidence of adherence to adjacent organs (Table 2,
p< 0.01), signs of diarrhoea in 100% of the colitic ani-
mals and a reduction in food intake compared with the
noncolitic rats (data not shown).
Histological assessment of the colonic samples from the
TNBS control group revealed severe transmural disrup-
tion of the normal architecture of the colon, extensive
ulceration, inflammation involving all the intestinal
layers of the colon, and a marked neutrophill infiltration
(Figure 1B). The colonic samples from the TNBS control
group received a microscopic score of 10.5 (Table 2),
which differed significantly from that for the noncolitic
groups (p< 0.01). The colonic damage was biochemically
characterised by a significant reduction (p< 0.01) in co-
lonic GSH levels (Figure 2), a 3.8-fold increase in MPO
activity (p< 0.01) and a 2.8-fold increase (p< 0.01) in
AP activity (Figures 3 and 4) as compared with the non-
colitic rats.
The treatment of noncolitic rats with the 20% cattail
rhizome diet for 21 days had no effect on the colon
weight and there were no signs of diarrhoea or adher-
ence to adjacent organs. In addition, we observed no ef-
fect on GSH levels or MPO and AP activities, and all the
results in the noncolitic rats that received the 20% cattail
rhizome diet were similar to those for the untreated non-
colitic group (Table 2, Figures 2–4). Interestingly, the
dietary treatment of the colitic rats for 14 days prior to
the induction of colitis and 7 days thereafter showed an
overall lower impact of TNBS-induced colonic damage
compared with the TNBS control group.
The colitic rats treated with 5% and 10% cattail
rhizome flour showed a faster weight gain in comparison
Table 2 Effects of different treatments on damage score, extension of lesion, changes in colon weight, adherences to
adjacent organs and microscopic score
Experimental Groups Scorea(0–10) Extension of lesionb (cm) Colon weightb(mg/cm) Adherence(%) Microscopic Score (0-27) a
Non-colitic groups
Non treated 0*** 0** 112.68 ± 6.28** 0** 0**
20% diet 0*** 0** 113.63 ± 5.56** 0* 0**
Colitic groups
TNBS-Control 7 (4–8) 3.04 ± 0.33 260.63 ± 37.62 60 10.5 (5–19)
5% diet 6 (0–7) 1.67 ± 0.42* 156.67 ± 16.76* 15* 8 (5–15)
10% diet 5 (4–6) 1.45 ± 0.29* 169.24 ± 6.12* 0* 5 (3–11)
20% diet 6 (4–8) 2.17 ± 0.36 204.75 ± 22.81 85 4 (2–10)
5% diet + prednisolone 7 (5–10) 3.24 ± 0.59 196.73 ± 23.22 15* 5 (2–14)
10% diet + prednisolone 6 (5–7) 2.43 ± .029 156.01 ± 9.87* 45 7 (2–11)
20% diet + prednisolone 6 (0–8) 2.41 ± 0.68 258.04 ± 63.77 45 5 (1–9)
prednisolone 3 (0–4)* 1.40 ± 0.27* 162.20 ± 8.14* 45 11.0 (8–14)
a Score and microscopic score data are expressed as median (range) and were statically evaluated by non-parametric Kruskal-Wallis test; b Extension of lesion and
colonic weight data are expressed as mean ± SEM values and differences were assessed using ANOVA was followed by post hoc test of Dunnet; Adherence was
expressed in percentage and was analyzed with the χ2 test. *P< 0.05, P< 0.01 and P< 0.001 versus TNBS control group.
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TNBS control group (7.5 ± 0.92 weight gain in the
treated rats vs. 12.5 ± 3.1% weight loss in TNBS con-
trol rats), but no effect on weight gain was observed
in the rats that were treated with 20% cattail rhizome
diet (12.5 ± 3.1% weight loss in the TNBS control rats
vs. 1.42 ± 0.62 weight gain in the treated rats). Feeding
a 5% or 10% cattail rhizome diet to the colitic rats
resulted in a significant reduction in the extension of
the lesions (1.67 ± 0.42 and 1.45± 0.29, respectively, in
the treated rats vs. 3.04± 0.33 in the TNBS controls,
p< 0.05), the weight/length ratio (156.67± 16.76 and
169.24± 6.12, respectively, in the treated rats vs.
260.63± 37.62 in the TNBS controls, p< 0.05) and the
incidence of adherence to adjacent organs (15% and 0%,
respectively, in the treated rats vs. 60% in the TNBS
controls, p< 0.05) (Table 2). Interestingly, the dietary
intervention with 20% cattail rhizome flour did not pro-
duce any effects on these parameters. No effects were
observed in the microscopic scores after all the cattail
rhizome treatments, but the histological studies showed
that the flour treatment was able to ameliorate some
of the processes involved in colon inflammation (pri-
marily leukocyte infiltration) compared with the TNBS con-
trols (Figure 1D and 1E). The intestinal anti-inflammatory
effect was also observed biochemically by significant coun-
teractions of the colonic GSH level compared with
the TNBS control group (Figure 2, p< 0.01). In the
rats treated with 5% and 10% cattail rhizome flour,
the observed decrease in leukocyte infiltration
observed with histological studies was confirmed by
a significant reduction in MPO activity (Figure 3,
p< 0.05 and p< 0.01for the 5% and 10% cattail flour,respectively). In addition, AP activity was signifi-
cantly reduced (p< 0.05) in the rats fed the 10%
dietary cattail rhizome diet, whereas AP activity was
increased in the TNBS control group (Figure 4).
When colitic rats were treated with a combination of the
cattail rhizome diet and prednisolone, protective effects
were observed in the rats that received the 10% cattail rhi-
zome flour; however, the combination of prednisolone and
the diet containing 5% or 20% cattail rhizome flour showed
no effect on the macroscopic and microscopic scores, the
extension of the lesion, the colon weight ratio or the adher-
ence to adjacent organs (Table 2). The combination of
prednisolone and the diets containing 5% or 10% cattail
rhizome flour displayed a significant beneficial effect in the
colitic rats, as evidenced by an attenuation of the depletion
of GSH (Figure 2, p< 0.01) and a reduction of MPO activ-
ity (Figure 3, p< 0.05 and p< 0.01 for 5% and 10% cattail
flour, respectively). Interestingly, only the combination of
the 10% cattail rhizome flour and prednisolone was able to
significantly inhibit AP activity (Figure 4, p< 0.05). This
effect was also confirmed by histological studies that
showed a pronounced recovery of colon cytoarchitecture
accompanied by a mild ulceration in mucosa and a reduc-
tion of the inflammatory cells in the submucosa (Figure 1F
and 1G).
Prednisolone, which was used as a reference drug,
showed anti-inflammatory effects as evidenced by
significant reductions in the macroscopic score, the
extension of the lesion and the colon weight ratio
(Table 2, p< 0.05). The protective effects of prednisolone
were also biochemically related to a reduction of MPO
activity (Figure 3, p< 0.05). Histological analysis also







Figure 1 Photomicrography of colon of different groups: (A) Non-colitic group; (B) TNBS-control group; (C) prednisolone (2 mg/kg); (D) 5%
cattail rhizome flour; (E) 10% cattail rhizome flour; (F) 5% cattail rhizome flour + prednisolone (2 mg/kg); (G) 10% cattail rhizome flour +
prednisolone (2 mg/kg).
Fruet et al. BMC Complementary and Alternative Medicine 2012, 12:62 Page 6 of 11
http://www.biomedcentral.com/1472-6882/12/62had no effect on the microscopic scores, the adherences
to adjacent organs (Table 2), the GSH level or AP activity
(Figure 4).Microbiological analysis
No significant difference in the lactic acid bacteria



























































































Figure 2 Effects of different treatments on colon glutathione
(GSH) content. Data are expressed as mean ± S.E.M. Differences
were assessed using analysis of variance (ANOVA) was followed by
post hoc tests of Dunnett. *p< 0.05, **p< 0.01 vs. TNBS-control.
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flour did not promote any alterations in the lactic acid
bacteria counts in the noncolitic or the colitic rats (data
not shown).
Anti-oxidant activity
The in vitro antioxidant experiments demonstrated that
























































































Figure 3 Effects of different treatments on myeloperoxidase
(MPO) activity. Data are expressed as mean ± S.E.M. Differences
were assessed using analysis of variance (ANOVA) was followed by
post hoc tests of Dunnett. *p< 0.05, **p< 0.01 vs. TNBS-control.inhibitory effect on the lipid peroxidation induced in rat
brain membranes, with an IC50 value of 116.14 ±
4.91 μg/ml. The corresponding IC50 value of quercetin
was 0.39 ± 0.02 μg/ml.
Qualitative phytochemical analysis
The qualitative phytochemical analysis indicated the
presence of saponins, flavonoids and coumarin deriva-
tives in the cattail rhizome flour.
Discussion
Current pharmacological treatments for IBD include
a series of compounds, such as aminosalicylates,
corticosteroids, biological agents and immunosup-
pressants, but the long-term use of these drugs
results in unwanted and serious side effects. There-
fore, a combination of products that improve the
anti-inflammatory activity of drugs would be an
important approach for IBD treatment. The present
study was designed to evaluate novel experimental
interventions using cattail rhizome flour as a poten-
tial dietary product and complementary agent to be
used in association with prednisolone, which is used
for treatment of human IBD.
Initially, we evaluated the effects of enriched diet with
20% cattail rhizome flour in healthy rats. After three
weeks, we did not observe any diet-induced changes in
food intake or in clinical, macroscopic, microscopic or
biochemical parameters (data not shown), which
suggested that cattail rhizome flour is a safe product for
use in the diet and is palatable to rats.
In another set of experiments, we evaluated the effects of
5%, 10% and 20% cattail rhizome flour on the intestinal
inflammatory process induced by TNBS in rats. Our data
demonstrate that 5% and 10% cattail rhizome diets pre-
vented intestinal inflammatory processes, whereas 20% cat-
tail rhizome flour only prevented GSH depletion induced
by TNBS. The protective effects produced by dietary treat-
ment with 5% and 10% cattail rhizome flour were similar to
those produced by prednisolone.
We also evaluated the effects of cattail rhizome flour
on the intestinal anti-inflammatory activity of prednisol-
one to investigate whether cattail rhizome flour improves
the pharmacological activity of this currently used gluco-
corticoid. Our results revealed that the combination of
prednisolone (2 mg/kg) and the 10% cattail rhizome diet
was effective in preventing the intestinal inflammatory
process induced by TNBS in rats. Interestingly, there
was no evidence of synergistic effects for this combin-
ation treatment.
In all of the experiments, we evaluated the effect
exerted by the cattail rhizome flour diet on the growth
and development of lactic bacteria, and we demonstrated





























































































Figure 4 Effects of different treatments on alkaline phosphatase (AP) activity. Data are expressed as mean ± S.E.M. Differences were
assessed using analysis of variance (ANOVA) was followed by post hoc tests of Dunnett. *p< 0.05, **p< 0.01 vs. TNBS-control.
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However, the methods used to determine bacteria growth
and development are limited, and new studies are neces-
sary, particularly studies that use more appropriate and
specific culture medium and evaluation of other bacteria
with prebiotic effects (e.g., bifidobacteria).
The detected intestinal anti-inflammatory activity of
Typha angustifolia rhizomes correlates with traditional
uses against inflammation and diarrhoea [7-10]. Few
pharmacological studies with Typha angustifolia have
been performed, but its effects as an immunoregulating
product can corroborate the anti-inflammatory activity
that was demonstrated in the present study [35]. This
plant has also been described as a potential anti-aging
and antidiabetic agent and has been shown to improve
metabolism and reduce aldose reductase in streptozoto-
cin-induced diabetic mice [35,36]. Several plants of the
genus Typha have been proved to exert anti-inflammatory
effects related to inhibition of neutrophil functions;
inhibition of nitric oxide, interleukin-4, interleukin-5,
interleukin 13 and prostaglandin production; and
inhibition of the expression of inducible nitric oxide syn-
thase and cyclo-oxygenase 2 [37-39].
Cattail rhizome flour attenuated the GSH depletion
induced by colonic inflammatory processes and restored
the levels toward the normal value. GSH depletion after
intestinal damage in rats is a typical characteristic of colitis
induced by TNBS [11,12,34,40,41]. GSH plays a key role in
controlling the redox state of the cell by acting as a scav-
enger of reactive oxygen species and keeping the enzyme
GSH peroxidase in a reduced state [42]. Indeed, studieshave reported that GSH supplementation improves
oxidative damage in TNBS colitis [43]. Thus, the use
of antioxidant compounds may be useful in limiting
damage in IBD. Interestingly, studies have proposed
that antioxidant activity may be partially responsible
for the beneficial effects of glucocorticoids (primarily
prednisolone), such as the inhibition of nitric oxide
production in intestinal inflammation [44]. Indeed,
previous studies have shown the beneficial effects of
different antioxidant compounds in experimental mod-
els of rat colitis, including flavonoids [45] vitamin E
[46], tempol [47], and coumarin derivatives [34,40,41].
In addition, the antioxidant effect of cattail rhizome flour
was confirmed by an in vitro lipid peroxidation assay. This
activity was lower than the effects of quercetin but com-
parable to the standardised plant extracts of Vochysia
tucanorum, Baccharis dracunculifolia, Coccoloba uvifera
and Cissus cyssoides [48-51].
The intestinal anti-inflammatory activity of the cattail
rhizome flour supplementation was also related to an
inhibitory effect on MPO activity. MPO, an enzyme
found predominantly in the azurophilic granules of
neutrophils, is a biochemical marker of neutrophil infil-
tration, and measurements of its activity have been
widely used to detect intestinal inflammatory processes
[52,53]. Reduction of MPO activity can be interpreted as
a manifestation of the anti-inflammatory property of a
given compound [54]. Colonic tissue MPO activity,
which was markedly elevated in the TNBS control rats,
was significantly decreased in the rats treated with diet-
ary cattail rhizome flour, and this effect was supported
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histological analysis.
Human IBD is characterised by an increased expression
of markers of differentiation and AP, which is upregulated
in experimental chronic diarrhoea, has been considered a
phenotypic marker of differentiation, [55]. Moreover,
colonic tissue AP activity has been used to differentiate
Crohn’s disease from ulcerative colitis because AP enzym-
atic activity is higher in Crohn’s disease [56]. A recent study
showed that intestinal AP mRNA expression is reduced in
patients with UC and CD and that oral administration of
active intestinal AP enzymes in the rat intestinal tract
results in a significant reduction of inflammation [57]. In
the present study, colon AP activity in colitic rats was sig-
nificantly increased as compared with the noncolitic rats.
After treatment with 10% cattail rhizome flour or the com-
bination of 10% cattail rhizome flour and prednisolone, an
inhibitory effect on the AP activity was detected. Because
prednisolone was ineffective in inhibiting this enzymatic ac-
tivity by itself, it is possible that the inhibitory effect pro-
duced by the combination of cattail and prednisolone is
related to the use of 10% cattail rhizome flour.
Finally, our qualitative phytochemical studies revealed the
presence of flavonoids, coumarins and saponins in cattail
rhizome flour. Various antioxidant flavonoids and coumarin
derivatives have been reported as protective products to
prevent and treat intestinal inflammatory processes
induced by different chemical inductors of experimen-
tal colitis [34,40,41,45]. Several studies have shown that
different saponins from Panax ginseng and Codonopsis
lanceolata were active compounds in experimental colitis
[58-60]. Hence, it is plausible that the presence of these
classes of natural compounds in the rhizome flour of cat-
tail contribute to the observed intestinal anti-inflamma-
tory activity.
Conclusions
Based on our results, we conclude that dietary supplemen-
tation with 10% cattail rhizome flour and its combination
with prednisolone prevent TNBS-induced colonic damage
in rats. This effect was associated with an improvement in
intestinal oxidative stress, probably derived from antioxi-
dant properties of active compounds detected in the cattail
rhizome, especially flavonoids and coumarins. Indeed, the
observed protective effect was not related to an improve-
ment in lactic bacteria counts. The present results suggest
that cattail rhizome flour constitutes an important dietary
supplement and complementary medicinal product for the
prevention and treatment of human IBD. Because of
limitations of the study, however, further studies are ne-
cessary to gain more knowledge about the intestinal anti-
inflammatory properties and the chemical composition of
cattail rhizome flour.Competing interests
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